Inicio/Acciones/SABSW

SABSW

USD

SAB Biotherapeutics Inc. Warrant

$0.028-0.020 (-41.300%)

Precio en Tiempo Real

Healthcare

Biotecnología

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$0.048

Máximo

$0.039

Mínimo

$0.028

Volumen

0.01M

Fundamentos de la Empresa

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.028Actual $0.028Máximo $0.0391

Noticias Relacionadas

4 nov 2025 · 13:30

GlobeNewswire

SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other

4 nov 2025 · 13:00

GlobeNewswire

SAB BIO to Participate in Upcoming Investor Conferences

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its